| Display title | Medicine:Onyx (interventional radiology) |
| Default sort key | Onyx (interventional radiology) |
| Page length (in bytes) | 1,823 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 858202 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Rtexter1 |
| Date of page creation | 12:14, 25 July 2021 |
| Latest editor | imported>Rtexter1 |
| Date of latest edit | 12:14, 25 July 2021 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | In interventional radiology, Onyx is a trade name for a copolymer used for embolisation therapy, which involves the occlusion of blood vessels. It is a liquid embolic agent. Onyx is produced and sold by Medtronic (previously Covidien, which acquired ev3 Inc., the original developer of Onyx, in 2010) |
